KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

ClearPoint Neuro (CLPT) EBIT Margin (2018 - 2025)

Historic EBIT Margin for ClearPoint Neuro (CLPT) over the last 13 years, with Q3 2025 value amounting to 59.54%.

  • ClearPoint Neuro's EBIT Margin rose 39600.0% to 59.54% in Q3 2025 from the same period last year, while for Sep 2025 it was 66.31%, marking a year-over-year decrease of 45200.0%. This contributed to the annual value of 62.91% for FY2024, which is 308000.0% up from last year.
  • Per ClearPoint Neuro's latest filing, its EBIT Margin stood at 59.54% for Q3 2025, which was up 39600.0% from 61.64% recorded in Q2 2025.
  • In the past 5 years, ClearPoint Neuro's EBIT Margin ranged from a high of 54.12% in Q1 2021 and a low of 119.85% during Q2 2023
  • Its 5-year average for EBIT Margin is 77.49%, with a median of 73.75% in 2022.
  • As far as peak fluctuations go, ClearPoint Neuro's EBIT Margin tumbled by -470300bps in 2021, and later skyrocketed by 597300bps in 2024.
  • Over the past 5 years, ClearPoint Neuro's EBIT Margin (Quarter) stood at 92.99% in 2021, then rose by 7bps to 86.37% in 2022, then increased by 20bps to 69.1% in 2023, then fell by -5bps to 72.68% in 2024, then grew by 18bps to 59.54% in 2025.
  • Its last three reported values are 59.54% in Q3 2025, 61.64% for Q2 2025, and 72.63% during Q1 2025.